Evidence map›Paper›PMID 19266336›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2009

Transposon mutagenesis in mice.

David A Largaespada

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.Translational research : the journal of laboratory and clinical medicine · 2013
    Review
  5. The Mammalian Phenotype Ontology as a unifying standard for experimental and high-throughput phenotyping data.Mammalian genome : official journal of the International Mammalian Genome Society · 2012
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Probing human cardiovascular congenital disease using transgenic mouse models.Progress in molecular biology and translational science · 2011
    Review
  12. Review
  13. Review
  14. Transposon transgenesis in Xenopus.Methods (San Diego, Calif.) · 2010
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

David A LargaespadaUniversity of Minnesota, Department of Genetics, Cell Biology and Development, Minneapolis, MN, USA.
University of Minnesota · US

Funding

Xenograft Core for NF1 Experimental TherapeuticsP50NS057531 · NINDS · CINCINNATI CHILDRENS HOSP MED CTR · PI RATNER, NANCY · 2008 to 2012
$6.8M
Sleeping Beauty for uncovering cancer genes in miceR01CA113636 · NCI · UNIVERSITY OF MINNESOTA · PI LARGAESPADA, DAVID ANDREW · 2006 to 2016
$2.5M
Transposon-based screens for colorectal cancer genesR01CA134759 · NCI · UNIVERSITY OF MINNESOTA · PI CORMIER, ROBERT T, LARGAESPADA, DAVID ANDREW · 2009 to 2013
$1.5M
Transposon Mutagenesis Development and Drug AbuseR01DA014764 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LARGAESPADA, DAVID ANDREW · 2003 to 2005
$959k
Transposon-based somatic mutagenesis/prostate cancer geneticsR21CA118600 · NCI · UNIVERSITY OF MINNESOTA · PI LARGAESPADA, DAVID ANDREW · 2006 to 2007
$385k
NCI NIH HHS R01 CA113636NCI NIH HHS R01 CA134759NCI NIH HHS R21 CA118600NIDA NIH HHS R01 DA014764NINDS NIH HHS P50 NS057531
6 · The paper itself

Abstract

Understanding the functional landscape of the mammalian genome is the next big challenge of biomedical research. The completion of the first phases of the mouse and human genome projects, and expression analyses using microarray hybridization, generate critically important questions about the functional landscape and structure of the mammalian genome: how many genes, and of what type, are there; what kind of functional elements make up a properly functioning gene? One step in this process will be to create mutations in every identifiable mouse gene and analyze the resultant phenotypes. Transposons are being considered as tools to further initiatives to create a comprehensive resource of mutant mouse strains. Also, it may be possible to use transposons in true forward genetic screens in the mouse. The "Sleeping Beauty" (SB) transposon system is one such tool. Moreover, due to its tendency for local hopping, SB has been proposed as a method for regional saturation mutagenesis of the mouse genome. In this chapter, we review the tools and methods currently available to create mutant mice using in vivo, germline transposition in mice.

Indexed as

AnimalsDNA Transposable ElementsGene TargetingGerm-Line MutationMiceMice, TransgenicMutagenesis, InsertionalDNA Transposable Elements

Identifiers

PMID19266336
PMCPMC2984597
OpenAlexW1838068818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.